VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1661729
Sex: M
Age:
State: FL

Vax Date: 04/13/2021
Onset Date: 04/16/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210418; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210417; Test Name: Body temperature; Result Unstructured Data: Test Result:103.5; Test Date: 20210416; Test Name: Body temperature; Result Unstructured Data: Test Result:101

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Migraine; Dizziness; Multiple bloody noses throughout the day; Started feeling flu symptoms; Tired; Weak; Body ache; Fever of 101; fever went went up to 103.5 on 17Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on 13Apr2021 (at the age of 35-years-old); as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021, the patient started feeling flu symptoms, tired, weak, body aches and fever of 101. On 17Apr2021, fever went up to 103.5 and patient started having migraines, dizziness and multiple bloody noses throughout the day. Fever came and went until 19Apr2021 (at the time of report), but was still experiencing bloody noses, body ache and migraines. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included COVID-19 virus test on 18Apr2021 and the results were pending. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events started feeling flu symptoms, tired, weak, body ache, multiple bloody noses, dizziness and migraine were not recovered at the time of this report. The clinical outcome of fever of 101, fever went up to 103.5 was recovered on 19Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661730
Sex: F
Age:
State: MA

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210409; Test Name: COVID-19 virus test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Large bump; Large bump hot to touch; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 11:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and for unspecified indication and experienced drug allergy. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Mar2021 at 12:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On 09Apr2021, the patient underwent for COVID-19 virus test (nasal swab) and the results were found to be negative. On 17Apr2021 the patient experienced the event large bump hot to touch. Since the vaccination, the patient had been tested for COVID-19. No therapeutic measures were taken as the result of the reported events. The clinical outcome of the event large bump hot to touch was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1661731
Sex: F
Age:
State: PA

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: The site is painful and itchy.; The site is painful and itchy.; Red rash; Arm has been very sore; Headache; Body aches; Nausea; Large baseball size swelling at incision site the night after vaccination; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 20Apr2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included multi-vitamin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 02Apr2021 at 10:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021, the patient experienced large baseball size swelling at incision site the night after vaccination. On 21Apr2021 at 12:00, the site was painful and itchy. The patient developed red rash. The patient's arm had been very sore and all other side effects had been present like headache, body aches and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events large baseball size swelling at incision site, site was painful, itchy and red rash which included treatment with diphenhydramine hydrochloride (BENADRYL) and anti-itch cream (Unspecified). Therapeutic measures were not taken as a result of the events arm has been very sore, headache, body aches and nausea. The clinical outcome of the events large baseball size swelling at incision site the night after vaccination, site was painful, itchy, red rash, arm has been very sore, headache, body aches and nausea were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661732
Sex: M
Age:
State: TX

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Pain in left arm; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 14:30 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. On 22Apr2021, the patient experienced pain in left arm. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain in left arm was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1661733
Sex: F
Age:
State: GA

Vax Date: 04/18/2021
Onset Date: 04/20/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Muscles in neck close to jaw tight after event.; Chewing makes jaw lock.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 13:30 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic, allergy, seasonal allergy, and cramps. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included diphenhydramine, paracetamol, phenylpropanolamine hydrochloride (BENADRYL) for allergy and ibuprofen sodium (IBUPROFEN) for cramps. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Mar2021 at 14:45 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 06:00 the patient had mouth locked up and could not move jaw for a minute or so. Chewing made jaw lock. The patient could only chew in tiny bites. It started 2nd day after shot and muscles in jaw tight. Muscles in neck close to jaw tight after event. Symptom did not seem to be improving. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events muscle tightness and lock jaw were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: BENADRYL; IBUPROFEN

Current Illness:

ID: 1661734
Sex: F
Age:
State: WI

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Chills; Vomiting at about 5 times thru the night; Very tired; Night sweats; Dizzy; Very weak; Balance; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 11:00 (at the age of 79-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and sulpha allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 18:00 (at the age of 79-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 19:00, the patient experienced chills for about an hour, vomiting 5 times through the night, very tired, night sweats, very weak, dizzy and balance. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills, vomiting, very tired, night sweats, very weak, dizzy and balance was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SIMVASTATIN

Current Illness:

ID: 1661735
Sex: U
Age:
State: GA

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Muscle soreness; Tingling in right arm; Low grade fever; Chills; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 18Apr2021 at 12:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy (PCN allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not received any concomitant medication within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the arm left on 26Mar2021 at 12:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 18Apr2021 the patient experienced muscle soreness, tingling in right arm, low grade fever, chills and nausea. Therapeutic measures were taken as a result of muscle soreness, tingling in right arm, low grade fever, chills, and nausea and included treatment with Tylenol and Advil from unknown date. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event muscle soreness, tingling in right arm, low grade fever, chills, and nausea was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1661736
Sex: M
Age:
State: VA

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Nausea; Vomiting; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in left arm on 18Apr2021 at 16:15 (at the age of 16-years old), as a single dose for COVID-19 immunisation. Medical history included allergy to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19Apr2021, the patient had experienced nausea, vomiting, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events nausea, vomiting, headache and fatigue and which included treatment with acetaminophen. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, nausea, vomiting, headache and fatigue was recovering at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661737
Sex: F
Age:
State: TX

Vax Date: 04/09/2021
Onset Date: 04/13/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Nausea began 3-4 days after injection.I've had nausea for more than a week now.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 09Apr2021 at 18:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to black olives. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol (MANUFACTURER UNKNOWN). for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 14:00, the patient experienced nausea which began 3-4 days after injection, and the patient had nausea for more than a week now. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination the patient not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event nausea was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: PARACETAMOL

Current Illness:

ID: 1661738
Sex: M
Age:
State: HI

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 21Apr2021 at 12:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3) and zinc (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 31Mar2021 at 12:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 20:00, the patient experienced pain at injection site. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain at injection site was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN; HYDROCHLOROTHIAZIDE; VITAMIN D3; ZINC

Current Illness:

ID: 1661739
Sex: F
Age:
State: PA

Vax Date: 04/07/2021
Onset Date: 04/01/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 202104; Test Name: Blood test; Result Unstructured Data: Test Result:UNKNOWN RESULTS; Comments: "I am pending bloodwork as ordered by my doctor".

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Significant headaches; Fatigue; Dizziness; Ear aches; Ringing in the ears; Experienced the "normal" side effects which occurred within the first 48 hours of the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 07Apr2021 at 14:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included seasonal allergies (hay fever). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN), montelukast sodium (SINGULAIR), triamcinolone acetonide (NASACORT) and cetirizine hydrochloride (ZYRTEC); all taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and erythromycin ethylsuccinate; sulfafurazole acetyl (PEDIAZOLE) and experienced drug allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 14:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unspecified date in Apr2021, the patient initially experienced the "normal" side effects which occurred within the first 48 hours of the vaccine. On 10Apr2021 at 12:00 at the 72-hour mark, the patient experienced significant headaches, fatigue, dizziness, ear aches and ringing in the ears which were non-stop until about 21Apr2021 (2 whole weeks straight). The patient reported that while it had gotten a lot better, the side effects were not completely gone. The patient reported that as there was very little information about dizziness as a side effect and it was particularly scary when it lasted beyond the 3-4 days that most information sites quoted as the typical side effect period for the vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with prednisone (MANUFACTURER UNKNOWN), 40 mg (milligrams) once per day for 3 days. On an unknown date in Apr2021, the patient had a bloodwork done which was ordered by the patients' doctor, the results of which were unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events "normal" side effects which occurred within the first 48 hours of the vaccine, significant headaches, fatigue, dizziness, ear aches and ringing in the ears was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PANTOPRAZOLE; VIT D [VITAMIN D NOS]; SINGULAIR; NASACORT; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1661740
Sex: F
Age:
State: FL

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: My arm is red; I have a bump; I have a bump, it is itchy and hot; I have a bump, it is itchy and hot; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 16Apr2021 at 09:30 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and the patient reported that "I can't have NSAIDS" (known allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (LEVOTHYROXIN), cetirizine hydrochloride (ZYRTEC) and ascorbic acid (VITAMIN C) and unspecified vitamins; all for unspecified indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 26Mar2021 at 09:30 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Apr2021 at 10:00, the patient's arm was red and had a bump, it was itchy and hot. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm was red and had a bump, it was itchy and hot was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXIN; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 1661741
Sex: F
Age:
State: GA

Vax Date: 04/06/2021
Onset Date: 04/01/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Soreness in arm; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERO729) via an unspecified route of administration in the left arm on 06Apr2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 at 14:00, the patient experienced soreness in arm and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with Tylenol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events soreness in arm and headache was recovered on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1661742
Sex: F
Age:
State: WA

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Feeling tingly just not right; This is a spontaneous report from a contactable nurse. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an intramuscular route of administration in the left arm on 22Apr2021 at 11:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included diphenhydramine hydrochloride (BENADRYL) from an unknown date for an unknown indication and unknown if ongoing. On 22Apr2021 at 12:00, the patient complained of (c/o) feeling tingly just not right. The patient had no shortness of breath (sob) or any other allergic reaction. The symptoms resolved without (w/o) intervention. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of event feeling tingly just not right was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: BENADRYL

Current Illness:

ID: 1661743
Sex: F
Age:
State:

Vax Date: 04/20/2021
Onset Date: 04/01/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: she had a mass underneath her left arm; sore muscle sand such; This is a spontaneous report from a contactable reporter (patient). A 59-years-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 20Apr2021 as dose 2, single in the left arm for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on unspecified date as dose 1, single for covid-19 immunisation. On Apr2021, the patient experienced sore muscle sand such and on 22Apr2021 she had a mass underneath her left arm that was not there two days ago, and states that this is the same arm that she received her injection in. The outcome of the events was unknown. No follow-up attempts are needed. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1661744
Sex: F
Age:
State: DC

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Sore throat; headache; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0171) via an unspecified route of administration in the arm left on 21Apr2021 at 16:30 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The medical history included allergy to penicillin and sulfa drug. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 22Apr2021 at 14:00, the patient experienced sore throat, headache and tiredness. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore throat, headache and tiredness was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661745
Sex: F
Age:
State: NY

Vax Date: 04/18/2021
Onset Date: 04/01/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Cramp-like pain between shoulder where I got the injection (left) and top of neck; Cramp-like pain between shoulder where got the injection (left) and top of neck; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 14:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products (reported as not that the patient known of). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medicines within two weeks of vaccination. On an unknown date in Apr2021, the patient experienced cramp-like pain between shoulder where the patient got the injection (left) and top of neck. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events cramp-like pain between shoulder where the patient got the injection (left) and top of neck was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1661746
Sex: F
Age:
State: FL

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Weak; Headaches; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 17Apr2021 at 10:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included thalassemia minor and cervical dystonia. The patient had known allergies to mushrooms. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 27Mar2021 at 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously took cefalexin (KEFLEX) and ciprofloxacin (CIPRO) for unknown indication on an unknown date and experienced drug allergy. On 18Apr2021 at 19:00, the patient experienced weak, headaches and tiredness. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of events weak, headaches and tiredness were resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661747
Sex: M
Age:
State: NM

Vax Date: 03/12/2021
Onset Date: 04/09/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20191119; Test Name: Thyroid function test; Result Unstructured Data: Test Result:2.86; Comments: Thyroid levels were 2.86; Test Date: 20210409; Test Name: Thyroid function test; Result Unstructured Data: Test Result:4.98; Comments: Doctor told me my thyroid levels had gone up to 4.98

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: thyroid levels had gone up to 4.98; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 12Mar2021 at 12:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, high blood pressure and mitral valve prolapse. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN); both from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 13:15, three weeks after receiving the second shot, the patient underwent blood work because of physical coming up. On the day of the blood draw doctor told him that the thyroid levels had gone up to 4.98 (unspecified units) and put the patient on levothyroxine to lower. The patient had planned to retest in 6 weeks. The previous reading of the patient was 2.86 (unspecified units) on 19Nov2019. The patient reported that he did not have history of hypothyroidism, so found this to be strange. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included treatment with levothyroxine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event thyroid levels had gone up to 4.98 was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN; METOPROLOL

Current Illness:

ID: 1661748
Sex: F
Age:
State: TX

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Sore arm; Slight headache; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 15Apr2021 at 10:45 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN), vitamin b complex (VITAMIN B), ascorbic acid, colecalciferol, zinc citrate, allium sativum bulb, sambucus nigra fruit, piper nigrum fruit, echinacea purpurea whole plant (IMMUNETI), fexofenadine hydrochloride (ALLEGRA) and probiotic (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 25Mar2021 at 15:00 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. On 15Apr2021, the patient experienced sore arm and slight headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen (ADVIL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm and slight headache were resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D NOS; VITAMIN B [VITAMIN B COMPLEX]; IMMUNETI; ALLEGRA

Current Illness:

ID: 1661749
Sex: F
Age:
State: WA

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Nausea; Dizzy when standing, versus within normal limits; This is a spontaneous report from a contactable nurse. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an intramuscular route of administration in the left arm on 22Apr2021 at 11:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. The patient had no known drug allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 22Apr2021 at 11:45, the patient experienced nausea and dizzy when standing, versus within normal limits (wnl). The events resulted in emergency room/department visit or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events nausea and dizzy when standing, versus within normal limit was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661750
Sex: M
Age:
State: GA

Vax Date: 04/01/2021
Onset Date: 04/04/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: My idiopathic iritis has been flaring up non-stop since my shot.; My idiopathic iritis has been flaring up non-stop since my shot.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 14:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included idiopathic iritis and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included full spectrum cannabidiol (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 07:00 the idiopathic iritis had been flaring up non-stop since his shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of idiopathic iritis and included treatment with Durezol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event idiopathic iritis was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: CANNABIDIOL

Current Illness: Iritis (idiopathic iritis)

ID: 1661751
Sex: M
Age:
State: NJ

Vax Date: 04/10/2021
Onset Date: 04/14/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Tinnitus in left ear. Persistent ringing as well as distortion of hearing. Symptoms first appeared 4 days after injection.; Tinnitus in left ear. Persistent ringing as well as distortion of hearing. Symptoms first appeared 4 days after injection.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ewo153) via an unspecified route of administration in the left arm on 10Apr2021 at 15:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) for unknown indication on unknown date and experienced drug allergy. The patient did not receive any concomitant medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced tinnitus in left ear. Persistent ringing as well as distortion of hearing. Symptoms first appeared on 14Apr2021 at 08:00, four days after injection. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of tinnitus in left ear, persistent ringing as well as distortion of hearing and included treatment with Prednisone 60milligram daily. The clinical outcome of the events tinnitus in left ear, persistent ringing as well as distortion of hearing was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661752
Sex: F
Age:
State:

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Still hurts on the second day after the vaccine but not swollen.; Right hand was swollen and hard to make a fist.; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP8735) via an unspecified route of administration in the right arm on 20Apr2021(at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included stroke. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included prasugrel (MANUFACTURER UNKNOWN), acetylsalicylic acid, ascorbic acid (ASPIRIN), bupropion hydrochloride (WELLBUTRIN) and chlortalidone (MANUFACTURER UNKNOWN); all for unknown indication and start date. The patient had no allergies to food, medication or other products. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 30Mar2021 at 11:30 as a single dose for COVID-19 immunisation. The patient got shot on the right arm and on the next day, on 21Apr2021 at 08:00, her right hand was swollen and hard to make a fist. Still hurt on the second day after the vaccine but not swollen. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right hand was swollen and hard to make a fist and still hurt on the second day after the vaccine but not swollen was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: PRASUGREL; ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID]; WELLBUTRIN; CHLORTHALIDONE

Current Illness:

ID: 1661753
Sex: F
Age:
State: VA

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Woke up with double vision in right eye.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 08Apr2021 at 14:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and nortriptyline (MANUFACTURER UNKNOWN); both for unknown indication and start date. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 09Apr2021 at 10:00, the patient woke up with double vision in right eye. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event woke up with double vision in right eye was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: GABAPENTIN; NORTRIPTYLINE

Current Illness:

ID: 1661754
Sex: F
Age:
State: MD

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Brain fog; Soreness at injection site; Soreness at shoulder; Headache; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 07Apr2021 at 12:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD) and penicillin allergy. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), ethinylestradiol; norgestrel (CRYSELLE) and cetirizine hydrochloride (ZYRTEC). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced brain fog, soreness at injection site and shoulder, headache and tiredness. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the events brain fog, soreness at injection site and shoulder, headache and tiredness was resolved on an unspecified date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LISDEXAMFETAMINE MESILATE; ETHINYLESTRADIOL;NORGESTREL; CETIRIZINE HYDROCHLORIDE

Current Illness:

ID: 1661755
Sex: M
Age:
State: CT

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Developed Vertigo next day. Vertigo lasted 4 days.; Achy and sore, whole right side sore, from ear to hip; Dizziness; Exhaustion/tired. Exhaustion lasted 6 days, still wiped out.; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 14Apr2021 at 10:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, diabetes and high cholesterol. The patient had known allergies to potatoes. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 11Mar2021 at 10:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 19:00, the patient experienced tired, achy and sore, whole right side sore from ear to hip, dizziness, exhaustion and nausea. On 15Apr2021, the patient experienced vertigo that lasted 4 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vertigo was resolved on 19Apr2021, after the duration of 4 days. The clinical outcome of the events tired, achy and sore, whole right side sore from ear to hip, dizziness, exhaustion and nausea was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661756
Sex: F
Age:
State: NV

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Still have a headache after 5 days; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Apr2021 at 11:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN); all taken for an unknown indication from an unknown date and unknown if it is ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Mar2021 at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient also received hydrocodone (MANUFACTURER UNKNOWN) and tramadol (MANUFACTURER UNKNOWN); for an unknown indication initiated on an unknown date and experienced drug allergy. On 18Apr2021, it was reported that the patient still had a headache after 5 days. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of event still have a headache after 5 days was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: MELOXICAM; LISINOPRIL; ATORVASTATIN

Current Illness:

ID: 1661757
Sex: M
Age:
State: CO

Vax Date: 04/15/2021
Onset Date: 04/17/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: I have strep sore throat symptoms. It hurt to eat, talk, and swallow.; got the shot on 04/15/2021 and notice my throat pain on 04/17/2021.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. The patient had unspecified medical history. The patient received unspecified concomitant medications within 2 weeks of vaccination. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, the patient experienced strep sore throat symptoms. It hurt to eat, talk, and swallow. He got the shot on 15Apr2021 and noticed his throat pain on 17Apr2021. It was unknown if therapeutic measures were taken as a result of the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event strep sore throat symptoms and throat pain were not recovered at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1661758
Sex: M
Age:
State:

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Injection arm has tingly feeling like its fallen asleep or like carpal tunnel.; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 20Apr2021 at 16:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 09:00, the patient's injection arm had tingly feeling like it was fallen asleep or like carpal tunnel. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event injection arm has tingly feeling like its fallen asleep or like carpal tunnel was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1661759
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Tingly mouth; Tired; Lump on arm where the injection was; This is a spontaneous report from a non-contactable consumer. An adult non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if the patient had received any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in 2021, after the first dose of COVID vaccine, the patient had a tingly mouth, tired, and lump on arm where the injection was given. All the side effects resolved within 48 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the reported events. The clinical outcome of the events tingly mouth, tired, and lump on arm where the injection was given were recovered within 48 hours on an unknown date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1661760
Sex: M
Age:
State: FL

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Experienced body aches; Tired; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 20Apr2021 at 16:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included controlled hypertension. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) 5 mg by mouth (PO) four times in a day (QD) and losartan (MANUFACTURER UNKNOWN) 50 mg by mouth (PO) four times in a day (QD) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the left arm on 30Mar2021 at 15:45 as a single dose for COVID-19 immunisation. On 21Apr2021 at 06:00, next morning following second dose the patient experienced body aches and was tired. This lasted for approximately 6 hours, by that evening was back to base line. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches and was tired recovered on 21Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE; LOSARTAN

Current Illness:

ID: 1661761
Sex: F
Age:
State: NJ

Vax Date: 04/17/2021
Onset Date: 04/19/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Have a bump/ tender spot on collarbone; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 17Apr2021 at 09:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included heart condition supraventricular tachycardia, allergy to latex and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified prescription medication for unknown indication on unknown date and unknown if ongoing. On 19Apr2021 at 09:00, 2 days after getting the second shot of vaccine, the patient noticed a bump/ tender spot on collarbone. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event bump/ tender spot-on collarbone was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1661762
Sex: F
Age:
State: TN

Vax Date: 03/29/2021
Onset Date: 04/16/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: A throbbing sharp jabbing pain on right side of head..A jolt throb next to ear and moves to back of head; A throbbing sharp jabbing pain on right side of head..A jolt throb next to ear and moves to back of head; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 29Mar2021 at 08:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 09:00, the patient experienced a throbbing sharp jabbing pain on right side of head and a jolt throb next to ear and moves to back of head, started 3 days before second shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event a throbbing sharp jabbing pain on right side of head and a jolt throb next to ear and moves to back of head was not recovered at the time of this report. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 08:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1661763
Sex: F
Age:
State: GA

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Completely achy all over from fingertips to toes- all joints; This is a spontaneous report from a non-contactable consumer. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 14:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient had received any other vaccines within four weeks prior to the vaccination. It was unknown whether the patient had taken any concomitant medications within two weeks. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 03Apr2021 at 07:30, the patient experienced completely achy all over from fingertips to toes- all joints. Therapeutic measure was taken as a result of the event completely achy all over from fingertips to toes- all joints and included treatment with Tylenol. Since the vaccination, the patient had not been tested for COVID-19.The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events- completely achy all over from fingertips to toes- all joints was recovered on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected

Other Meds:

Current Illness:

ID: 1661764
Sex: M
Age:
State: CO

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Improper handling of vaccines; Sore arm; Felt tired; This is a spontaneous report from a non-contactable consumer, the parent. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 16:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On an unknown date in Apr2021, the patient experienced a sore arm and felt tired after the first shot. The clinic where the patient took the first shot was put on evaluation pause to give vaccines due to improper handling of the vaccines. The reporter learned it in the newspaper and could not find more details. The local health department had recommended them to consider the patient's first shot invalid and asked to retake it. The patient had scheduled to take the second shot on 23Apr2021, at another clinic and the nurse there said they could discuss it when they were there whether the patient should take vaccine on 23Apr2021 (Friday) as a first or second shot. They were concerned about overdose or if it was necessary to re-do the first shot and should just treat the 23Apr2021 shot as the second shot. The reporter had requested for an advice. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm and felt tired were unknown at the time of the report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1661765
Sex: F
Age:
State: MA

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Body aches in the morning; Soreness at site; Fatigue; Some nausea; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 13:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included shrimp allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included multivitamin (MANUFACTURER UNKNOWN) on unknown date for unknown indication and unknown if ongoing. On 10Apr2021 at 13:45, first day, the patient experienced soreness at site, fatigue and some nausea. On 12Apr2021 third day, the patient experienced body aches in the morning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events soreness at site, fatigue, some nausea and body aches in the morning was resolved on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1661766
Sex: F
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Fever; Chills; Soreness; Swollen lymph nodes; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 13:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unknown blood pressure medication and vitamins both for unknown indication and form unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Mar2021 at 16:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 18:30 the patient experienced fever, chills, soreness, swollen lymph nodes and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events fever, chills, soreness, swollen lymph nodes and fatigue were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1661767
Sex: F
Age:
State:

Vax Date:
Onset Date: 04/19/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210419; Test Name: Exam; Result Unstructured Data: Test Result:Hepatomegaly; Test Name: Labs; Result Unstructured Data: Test Result:Elevated alkaline phosphatase and elevated GOT ...; Comments: Elevated alkaline phosphatase and elevated GOT (glutamic oxaloacetic transaminase); Test Name: Labs; Result Unstructured Data: Test Result:Persistent leukocytosis, iron deficiency anemia...; Comments: Persistent leukocytosis, iron deficiency anemia, elevated platelets.; Test Name: Labs; Result Unstructured Data: Test Result:Leukocytosis and iron deficiency anemia

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: On exam today She had hepatomegaly.; Fatigue; Weakness; This is a spontaneous report from a contactable physician. A non-pregnant female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021, as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date the patient experienced fatigue and weakness after vaccination. On the day of the report, upon physical examination, the patient had hepatomegaly. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, the patient underwent the lab tests and the test results revealed iron deficiency anemia and leukocytosis, the work up for which was ongoing. The most recent lab results. 2.5 months after vaccination, revealed persistent leukocytosis. iron deficiency anemia, elevated platelets, elevated alkaline phosphatase, elevated GOT (glutamic oxaloacetic transaminase) and elevated platelets. The clinical outcome of the event weakness and fatigue was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1661768
Sex: F
Age:
State: RI

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Side of left thigh pain from hip to knee; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 15:00 (at the age of 56-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 at 15:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had seasonal allergies. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR), montelukast (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN) and vitamin d nos (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received codeine (MANUFACTURER UNKNOWN) taken for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date in Mar2021, next day after first dose, the patient experienced side of left thigh pain from hip to knee. On 16Apr2021 at 18:00, the patient experienced same pain, only the pain began 3 days after the second shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left thigh pain from hip to knee was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ADVAIR; MONTELUKAST; FISH OIL; VITAMIN D NOS

Current Illness:

ID: 1661769
Sex: F
Age:
State: CA

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: headache; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8729) via an unspecified route of administration in the arm left on 07Apr2021 at 14:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 07Apr2021 at 20:00, the patient experienced headache and sore arm. Therapeutic measures were not taken as a result of the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events headache and sore arm were resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661770
Sex: F
Age:
State: MI

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Burning sensation in mouth from day one until today. 4/19/21. Not getting any better; Headaches; Migraine; Muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 06Apr2021 at 13:15 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included migraine and food allergy to garlic. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received codeine (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rizatriptan benzoate (MAXALT), diclofenac sodium (CATAFLAM), docusate sodium (STOOL SOFTENER), curcuma longa (TURMERIC) and VITAMINS; all of them started from an unknown date for unspecified indication and unknown if ongoing. On 06Apr2021, the patient experienced burning sensation in mouth which was not getting any better, headaches/migraines for 6 days and muscle pain for 5 days. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event- burning sensation in mouth was not recovered at the time of this report. The clinical outcome of the events- headaches/migraines was recovered on 12Apr2021. The clinical outcome of the event- muscle pain was recovered on 11Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: MAXALT; CATAFLAM [DICLOFENAC SODIUM]; STOOL SOFTENER; TURMERIC [CURCUMA LONGA]

Current Illness:

ID: 1661771
Sex: F
Age:
State: PA

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210408; Test Name: Body temperature; Result Unstructured Data: Test Result:102 Units:[degF]; Comments: 24 hr. post injection, spiked a temperature of 102F

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: 48 hr post injection: affected arm (L) became very hot; Rash developed upper L arm; developed upper L arm pain; Spiked a temperature of 102F; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0151) via an unspecified route of administration in the left arm on 07Apr2021 at 16:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included verapamil (MANUFACTURER UNKNOWN), hydrochlorothiazide, losartan (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient previously took flu vaccine (INFLUENZA VACCINE) for unknown indication on unknown date and experienced allergy. Also the patient previously took tizanidine hydrochloride(TIZANIDINE) for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6206) via an unspecified route of administration in the left arm on unknown date in Mar2021 at 16:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. On 08Apr2021, 24 hours post injection, the patient experienced spike in temperature for 102 degree Farenheit (degF) and fatigue. On 09Apr2021, 48 hours post injection, the patient upper left arm developed very hot, rash and pain. On 08Apr2021, the patient underwent lab test which included body temperature and the result was 102 (degF).Therapeutic measure was taken for the event spike in temperature which included MOTRIN. No therapeutic measures were taken as a result of the other reported events fatigue, upper left arm hot, rash and pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events spike in temperature for 102F was recovered after 4 hours on 08Apr2021, while that of the events upper left arm hot, rash and pain lasted for 3 days on 12Apr2021 and the outcome of the event fatigue was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VERAPAMIL; HYDROCHLOROTHIAZIDE;LOSARTAN

Current Illness:

ID: 1661772
Sex: U
Age:
State: WI

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Lower left back pain; headache; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old unknown gender patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 07Apr2021 at 10:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included lisinopril (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. On 08Apr2021, the patient experienced lower left back pain, headache and fatigue. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lower left back pain, headache and fatigue were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LISINOPRIL

Current Illness:

ID: 1661773
Sex: F
Age:
State: CO

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Sore arm; Chills; Headache; Body ache; Fatigue; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 18Apr2021 at 14:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included congenital heart disease. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included acetylsalicylic acid (ASPIRIN) and beta blocker; both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 28Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced sore arm, chills, headache, body ache, fatigue and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, chills, headache, body ache, fatigue and nausea was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ACETYLSALICYLIC ACID

Current Illness:

ID: 1661774
Sex: F
Age:
State: DE

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Lump on her collar bone; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 18Apr2021 at 00:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 19Apr2021, the patient discovered a lump on the collar bone in the arm where she received the vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of adverse event. The clinical outcome of the event lump on her collar bone was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661775
Sex: F
Age:
State: CO

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Nasal congestion; Significant body aches; Tiredness; Chills; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 09:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ethinylestradiol/ ferrous fumarate/ norethisterone acetate (LO LOESTRIN FE) and multivitamin (MANUFACTURER UNKNOWN) from unknown dates for unknown indications and unknown if ongoing. The patient previously received metoclopramide (REGLAN) and amoxicillin/clavulanic acid (AUGMENTIN) on unknown dates for unknown indications and experienced drug allergy. On 17Apr2021 at 20:00, (also reported as about 24-36 hours after the vaccine), the patient experienced tiredness, significant body aches, chills, and nasal congestion for several days. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tiredness, significant body aches, chills, and nasal congestion were recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LO LOESTRIN FE

Current Illness:

ID: 1661776
Sex: U
Age:
State: WA

Vax Date: 04/06/2021
Onset Date: 04/11/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Dehydration; Drowsiness; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old patient of unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 14:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 11Apr2021 at 15:00, the patient experienced dehydration and drowsiness. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were not taken as a result of reported events. The clinical outcomes of events dehydration and drowsiness were unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1661777
Sex: F
Age:
State: NY

Vax Date: 04/21/2021
Onset Date:
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: tenderness; swollen lymph nodes; headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 08:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any medication within two weeks of the COVID-19 vaccine. On an unknown date in 2021, the patient experienced fatigue, headache, tenderness, swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, headache, tenderness, swollen lymph nodes was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1661778
Sex: F
Age:
State: IN

Vax Date: 04/19/2021
Onset Date: 04/21/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Enlarged lymph nodes around left upper quadrant of the armpit and left subclavicle; Enlarged lymph nodes around left upper quadrant of the armpit and left subclavicle; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EAW0161) via an unspecified route of administration in the left arm on 19Apr2021 at 10:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant past medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included prenatal vitamin; taken for unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 29Mar2021 at 10:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 10:00, the patient experienced enlarged lymph nodes around left upper quadrant of the armpit and left sub clavicle. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event enlarged lymph nodes around left upper quadrant of the armpit and left subclavicle was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am